Your browser doesn't support javascript.
loading
Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial.
Wang, Xuan-Yi; Mahmood, Syed Faisal; Jin, Fang; Cheah, Wee Kooi; Ahmad, Muhammad; Sohail, Mian Amjad; Ahmad, Waheed; Suppan, Vijaya K; Sayeed, Muneeba Ahsan; Luxmi, Shobha; Teo, Aik-Howe; Lee, Li Yuan; Qi, Yang-Yang; Pei, Rong-Juan; Deng, Wei; Xu, Zhong-Hui; Yang, Jia-Ming; Zhang, Yan; Guan, Wu-Xiang; Yu, Xiong.
Affiliation
  • Wang XY; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, People's Republic of China.
  • Mahmood SF; Key Laboratory of Medical Molecular Virology of MoE & MoH, and Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China.
  • Jin F; Children's Hospital, Fudan University, Shanghai, People's Republic of China.
  • Cheah WK; Hospital of Aga Khan University, Karachi, Pakistan.
  • Ahmad M; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, Guangzhou, People's Republic of China.
  • Sohail MA; Guangzhou Joincare Respiratory Medicine Co., Ltd, Guangzhou, People's Republic of China.
  • Ahmad W; Department of Medicine and Clinical Research Centre, Taiping Hospital, Perak, Malaysia.
  • Suppan VK; Pulmonology & Critical care, Central Park Teaching Hospital, Lahore, Pakistan.
  • Sayeed MA; Shifa International Hospitals Ltd, Islamabad, Pakistan.
  • Luxmi S; Avicenna Medical College, Lahore, Pakistan.
  • Teo AH; Clinical Research Center, Sultan Abdul Halim Hospital, Kedah, Malaysia.
  • Lee LY; Department of Infectious Diseases, Sindh Infectious Diseases Hospital and Research Centre, Dow University of Health Sciences, Karachi, Pakistan.
  • Qi YY; Dow University of Health Sciences, Karachi, Pakistan.
  • Pei RJ; Penang General Hospital and Info Kinetics Clinical Research Centre, Pulau Pinang, Malaysia.
  • Deng W; CRC Seri Manjung Hospital, Perak, Malaysia.
  • Xu ZH; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, People's Republic of China.
  • Yang JM; Key Laboratory of Medical Molecular Virology of MoE & MoH, and Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China.
  • Zhang Y; Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People's Republic of China.
  • Guan WX; Guangzhou Joincare Respiratory Medicine Co., Ltd, Guangzhou, People's Republic of China.
  • Yu X; Livzon Mabpharm Inc., Zhuhai, People's Republic of China.
Emerg Microbes Infect ; 11(1): 1910-1919, 2022 Dec.
Article in En | MEDLINE | ID: mdl-35686572
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunization, Secondary / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Clinical_trials Limits: Humans Language: En Journal: Emerg Microbes Infect Year: 2022 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunization, Secondary / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Clinical_trials Limits: Humans Language: En Journal: Emerg Microbes Infect Year: 2022 Document type: Article Country of publication: Estados Unidos